InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: mtnman213 post# 139552

Wednesday, 02/10/2016 3:06:30 PM

Wednesday, February 10, 2016 3:06:30 PM

Post# of 402940
You might find this portion of the summary of interest from:

DEFENDANTS’ MEMORANDUM OF LAW IN SUPPORT OF THEIR MOTION TO DISMISS SECOND AMENDED COMPLAINT
https://ecf.nysd.uscourts.gov/doc1/127117615428

To the extent this Court reviews the allegations in Count I of the SAC, it will find that none states a claim for relief under the securities laws. To assist the Court in consideration of their motion to dismiss, the chart below summarizes Plaintiff’s seven allegedly materially false or misleading statements issued during the class period, see SAC ¶¶22-38 (Claims A-G), and Defendants’ primary arguments why each should be dismissed:






But, my favourite is still this bit about Dr Frei's relationship with the company:
https://ecf.nysd.uscourts.gov/doc1/127117615428
From page 29

In ¶55, Plaintiff alleges the Company falsely claimed the association of “Dr. Emil Frei, director and physician-in-chief emeritus at the Dana Faber Cancer Institute, and Dr. Har Gobind Khorana, a 1968 Nobel Prize Winner” with the Company, but, in fact, they were founding shareholders of the Company, see Ex. 20, (Stock Transfer Agent Report) at 5-6;


https://ecf.nysd.uscourts.gov/doc1/127117615749
Following two pics from pages 6 and 7 of exhibit 20:









In Reply to 'mtnman213'
Karin,
Is there some way to view those documents?



To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News